Since, no one else has taken a bite. Here we go, the real question should be why is market cap so low given the certainties which are in motion currently. This is not a pharma, so the trial is not all or nothing white knuckle trials.
More importantly we also now know how DuAVR behaves in human , there are 13 of those around keeping those extremely sick patients alive. More so than just keeping them alive, the data so far have been so outstanding that if I need a TAVR now, I would request for DUAVR on compassionate ground.
The figure of 50% market share is not a guess in optimism . It is derived at domination the VIV, valve in valve market set to be ~30% of all TAVR with another conservative 2% thrown in . You do the maths...
Since, no one else has taken a bite. Here we go, the real...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.35 |
Change
0.150(0.87%) |
Mkt cap ! $333.5M | |||
| Open | High | Low | Value | Volume |
| $17.19 | $17.39 | $16.90 | $350.7K | 20.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66 | $17.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |